The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Female Contraceptive-Global Market Insights and Sales Trends 2024
Synopsis
Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
The global Female Contraceptive market size is expected to reach US$ 22120 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Female Contraceptive in various end use industries. The expanding demands from the Online Stores and Retail Outlets, are propelling Female Contraceptive market. Female Contraceptive Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Female Contraceptive Drugs segment is estimated at % CAGR for the next seven-year period.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Female Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Female Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Female Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Female Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Female Contraceptive covered in this report include Merck, Pfizer, Allergan, Bayer, Okamoto Industries, Reckitt Benckiser, Lupin Pharmaceuticals, Foundation Consumer Healthcare and Teva Pharmaceuticals, etc.
The global Female Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Global Female Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Female Contraceptive market, Segment by Type:
Female Contraceptive Devices
Female Contraceptive Drugs
Global Female Contraceptive market, by Application
Online Stores
Retail Outlets
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Female Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Female Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
The global Female Contraceptive market size is expected to reach US$ 22120 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029. The market is mainly driven by the significant applications of Female Contraceptive in various end use industries. The expanding demands from the Online Stores and Retail Outlets, are propelling Female Contraceptive market. Female Contraceptive Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Female Contraceptive Drugs segment is estimated at % CAGR for the next seven-year period.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Female Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Female Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Female Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Female Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Female Contraceptive covered in this report include Merck, Pfizer, Allergan, Bayer, Okamoto Industries, Reckitt Benckiser, Lupin Pharmaceuticals, Foundation Consumer Healthcare and Teva Pharmaceuticals, etc.
The global Female Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Global Female Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Female Contraceptive market, Segment by Type:
Female Contraceptive Devices
Female Contraceptive Drugs
Global Female Contraceptive market, by Application
Online Stores
Retail Outlets
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Female Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Female Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Female Contraceptive Market Overview
1.1 Female Contraceptive Product Overview
1.2 Female Contraceptive Market Segment by Type
1.2.1 Female Contraceptive Devices
1.2.2 Female Contraceptive Drugs
1.3 Global Female Contraceptive Market Size by Type
1.3.1 Global Female Contraceptive Market Size Overview by Type (2018-2029)
1.3.2 Global Female Contraceptive Historic Market Size Review by Type (2018-2023)
1.3.3 Global Female Contraceptive Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Female Contraceptive Sales Breakdown by Type (2018-2023)
1.4.2 Europe Female Contraceptive Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Female Contraceptive Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Female Contraceptive Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Female Contraceptive Sales Breakdown by Type (2018-2023)
2 Global Female Contraceptive Market Competition by Company
2.1 Global Top Players by Female Contraceptive Sales (2018-2023)
2.2 Global Top Players by Female Contraceptive Revenue (2018-2023)
2.3 Global Top Players by Female Contraceptive Price (2018-2023)
2.4 Global Top Manufacturers Female Contraceptive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Female Contraceptive Market Competitive Situation and Trends
2.5.1 Female Contraceptive Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Female Contraceptive Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Contraceptive as of 2022)
2.7 Date of Key Manufacturers Enter into Female Contraceptive Market
2.8 Key Manufacturers Female Contraceptive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Female Contraceptive Status and Outlook by Region
3.1 Global Female Contraceptive Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Female Contraceptive Historic Market Size by Region
3.2.1 Global Female Contraceptive Sales in Volume by Region (2018-2023)
3.2.2 Global Female Contraceptive Sales in Value by Region (2018-2023)
3.2.3 Global Female Contraceptive Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Female Contraceptive Forecasted Market Size by Region
3.3.1 Global Female Contraceptive Sales in Volume by Region (2024-2029)
3.3.2 Global Female Contraceptive Sales in Value by Region (2024-2029)
3.3.3 Global Female Contraceptive Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Female Contraceptive by Application
4.1 Female Contraceptive Market Segment by Application
4.1.1 Online Stores
4.1.2 Retail Outlets
4.2 Global Female Contraceptive Market Size by Application
4.2.1 Global Female Contraceptive Market Size Overview by Application (2018-2029)
4.2.2 Global Female Contraceptive Historic Market Size Review by Application (2018-2023)
4.2.3 Global Female Contraceptive Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Female Contraceptive Sales Breakdown by Application (2018-2023)
4.3.2 Europe Female Contraceptive Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Female Contraceptive Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Female Contraceptive Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Female Contraceptive Sales Breakdown by Application (2018-2023)
5 North America Female Contraceptive by Country
5.1 North America Female Contraceptive Historic Market Size by Country
5.1.1 North America Female Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Female Contraceptive Sales in Volume by Country (2018-2023)
5.1.3 North America Female Contraceptive Sales in Value by Country (2018-2023)
5.2 North America Female Contraceptive Forecasted Market Size by Country
5.2.1 North America Female Contraceptive Sales in Volume by Country (2024-2029)
5.2.2 North America Female Contraceptive Sales in Value by Country (2024-2029)
6 Europe Female Contraceptive by Country
6.1 Europe Female Contraceptive Historic Market Size by Country
6.1.1 Europe Female Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Female Contraceptive Sales in Volume by Country (2018-2023)
6.1.3 Europe Female Contraceptive Sales in Value by Country (2018-2023)
6.2 Europe Female Contraceptive Forecasted Market Size by Country
6.2.1 Europe Female Contraceptive Sales in Volume by Country (2024-2029)
6.2.2 Europe Female Contraceptive Sales in Value by Country (2024-2029)
7 Asia-Pacific Female Contraceptive by Region
7.1 Asia-Pacific Female Contraceptive Historic Market Size by Region
7.1.1 Asia-Pacific Female Contraceptive Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Female Contraceptive Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Female Contraceptive Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Female Contraceptive Forecasted Market Size by Region
7.2.1 Asia-Pacific Female Contraceptive Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Female Contraceptive Sales in Value by Region (2024-2029)
8 Latin America Female Contraceptive by Country
8.1 Latin America Female Contraceptive Historic Market Size by Country
8.1.1 Latin America Female Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Female Contraceptive Sales in Volume by Country (2018-2023)
8.1.3 Latin America Female Contraceptive Sales in Value by Country (2018-2023)
8.2 Latin America Female Contraceptive Forecasted Market Size by Country
8.2.1 Latin America Female Contraceptive Sales in Volume by Country (2024-2029)
8.2.2 Latin America Female Contraceptive Sales in Value by Country (2024-2029)
9 Middle East and Africa Female Contraceptive by Country
9.1 Middle East and Africa Female Contraceptive Historic Market Size by Country
9.1.1 Middle East and Africa Female Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Female Contraceptive Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Female Contraceptive Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Female Contraceptive Forecasted Market Size by Country
9.2.1 Middle East and Africa Female Contraceptive Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Female Contraceptive Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Female Contraceptive Products Offered
10.1.5 Merck Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Female Contraceptive Products Offered
10.2.5 Pfizer Recent Development
10.3 Allergan
10.3.1 Allergan Company Information
10.3.2 Allergan Introduction and Business Overview
10.3.3 Allergan Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Allergan Female Contraceptive Products Offered
10.3.5 Allergan Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer Female Contraceptive Products Offered
10.4.5 Bayer Recent Development
10.5 Okamoto Industries
10.5.1 Okamoto Industries Company Information
10.5.2 Okamoto Industries Introduction and Business Overview
10.5.3 Okamoto Industries Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Okamoto Industries Female Contraceptive Products Offered
10.5.5 Okamoto Industries Recent Development
10.6 Reckitt Benckiser
10.6.1 Reckitt Benckiser Company Information
10.6.2 Reckitt Benckiser Introduction and Business Overview
10.6.3 Reckitt Benckiser Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Reckitt Benckiser Female Contraceptive Products Offered
10.6.5 Reckitt Benckiser Recent Development
10.7 Lupin Pharmaceuticals
10.7.1 Lupin Pharmaceuticals Company Information
10.7.2 Lupin Pharmaceuticals Introduction and Business Overview
10.7.3 Lupin Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Lupin Pharmaceuticals Female Contraceptive Products Offered
10.7.5 Lupin Pharmaceuticals Recent Development
10.8 Foundation Consumer Healthcare
10.8.1 Foundation Consumer Healthcare Company Information
10.8.2 Foundation Consumer Healthcare Introduction and Business Overview
10.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Foundation Consumer Healthcare Female Contraceptive Products Offered
10.8.5 Foundation Consumer Healthcare Recent Development
10.9 Teva Pharmaceuticals
10.9.1 Teva Pharmaceuticals Company Information
10.9.2 Teva Pharmaceuticals Introduction and Business Overview
10.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Teva Pharmaceuticals Female Contraceptive Products Offered
10.9.5 Teva Pharmaceuticals Recent Development
10.10 Ansell
10.10.1 Ansell Company Information
10.10.2 Ansell Introduction and Business Overview
10.10.3 Ansell Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Ansell Female Contraceptive Products Offered
10.10.5 Ansell Recent Development
10.11 Ferring Pharmaceuticals
10.11.1 Ferring Pharmaceuticals Company Information
10.11.2 Ferring Pharmaceuticals Introduction and Business Overview
10.11.3 Ferring Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Ferring Pharmaceuticals Female Contraceptive Products Offered
10.11.5 Ferring Pharmaceuticals Recent Development
10.12 Fuji Latex
10.12.1 Fuji Latex Company Information
10.12.2 Fuji Latex Introduction and Business Overview
10.12.3 Fuji Latex Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Fuji Latex Female Contraceptive Products Offered
10.12.5 Fuji Latex Recent Development
10.13 Janssen Pharmaceuticals
10.13.1 Janssen Pharmaceuticals Company Information
10.13.2 Janssen Pharmaceuticals Introduction and Business Overview
10.13.3 Janssen Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Janssen Pharmaceuticals Female Contraceptive Products Offered
10.13.5 Janssen Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Female Contraceptive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Female Contraceptive Industrial Chain Analysis
11.4 Female Contraceptive Market Dynamics
11.4.1 Female Contraceptive Industry Trends
11.4.2 Female Contraceptive Market Drivers
11.4.3 Female Contraceptive Market Challenges
11.4.4 Female Contraceptive Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Female Contraceptive Distributors
12.3 Female Contraceptive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
